IBIZ PLUS NETWORK CO.,LTD. Between December 17, 2021, and May 17, 2022, Ibiz Plus Network Co.,Ltd. have offered newly issued securities in the category of Crowdfunding bond without the approval from
securities in the category of shares (Public Offering) without approval from the SEC office which is in breach of the Securities and Exchange Act B.E. 2535. SEC Act S.34 in conjunction with Section 83 of
securities in the category of shares (Public Offering) without approval from the SEC office which is in breach of the Securities and Exchange Act B.E. 2535. SEC Act S.34 in conjunction with Section 83 of
approval from the SEC Office which is in breach of the Securities and Exchange Act B.E. 2535. SEC Act S.33 Settlement Committee Meeting No. 3/2025 Settlement Committee Order No. 40/2025 Dated 25/04/2025
) without the approval from the SEC Office which is in breach of the Securities and Exchange Act B.E. 2535 SEC Act S.33 Settlement Committee Meeting No. 5/2025 Settlement Committee Order No. 90/2025 Dated
Limited’s shares offering in the form of general or to the public without approval from the SEC office. SEC Act S.300 in conjunction with 34 Settlement Committee Meeting No. 7/2025 Settlement Committee
Assets by Subsidiary of DOD Biotech Public Company Limited for the Purchase and Acceptance of Transfer of the Entire Business of BGP Spectrum Power Co., Ltd., and Establishment of Subsidiary, Classified as
Assets by Subsidiary of DOD Biotech Public Company Limited for the Purchase and Acceptance of Transfer of the Entire Business of BGP Spectrum Power Co., Ltd., and Establishment of Subsidiary, Classified as
2.8% Revenue from finance lease under power purchase agreement 95.3 102.4 104.5 2.1% 9.7% 197.6 206.9 4.7% Cost of sales and services (1,174.0) (1,274.4) (1,191.7) (6.5%) 1.5% (2,323.4) (2,466.2) 6.1
Securities and Exchange Act B.E. 2535 (as amended); (d) the right to subscribe for the newly issued shares is still pending an approval by the Extraordinary General Meeting of Shareholders No.1/2017 The